Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2000
05/18/2000WO2000027805A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
05/18/2000WO2000027434A1 Combinations comprising a beta-agonist and a further antidiabetic agent
05/18/2000WO2000027422A2 Methods and compositions for treating or preventing peripheral neuropathies
05/18/2000WO2000027414A2 Inhibition of the formation of vascular hyperpermeability
05/18/2000WO2000027410A2 Composition and method for increasing weight gain and feed efficiency
05/18/2000WO2000027409A1 Production of a biological factor and creation of an immunologically privileged environment using genetically altered sertoli cells
05/18/2000WO2000027401A1 Combinations for diabetes which contain a sulfonylurea, a glitazone and a biguanide
05/18/2000WO2000027388A1 Glucose and lipid lowering compounds
05/18/2000WO2000027377A2 Phosphinate peptide analogs for the treatment of fibrotic disorders
05/18/2000WO2000027362A1 Method of producing vitamin powders
05/18/2000WO2000027359A1 An inhalation system
05/18/2000WO2000027341A2 Novel method of treatment
05/18/2000WO2000007606A3 Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
05/18/2000WO2000006140A3 Use of moclobemide for treating certain phsychiatric and medical disorders
05/18/2000DE19830770C1 Wasserlösliche Zinkpyruvate bzw. deren Hydrate, Verfahren zu ihrer Herstellung und deren Verwendung Water-soluble zinc pyruvate or hydrates thereof, processes for their preparation and their use
05/18/2000CA2351063A1 A system for administering a bioactive agent by inhalation comprising a lipid mixture comprising phosphatidylcholine
05/18/2000CA2350714A1 Spiro-indolines as y5 receptor antagonists
05/18/2000CA2350316A1 Methods and compositions to lower plasma cholesterol levels
05/18/2000CA2350213A1 Glucose and lipid lowering compounds
05/18/2000CA2350208A1 Antrhranilic acid amides and the use thereof as medicaments
05/18/2000CA2350062A1 Combinations comprising a beta-agonist and a further antidiabetic agent
05/18/2000CA2349951A1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
05/18/2000CA2349947A1 Method of producing vitamin powders
05/18/2000CA2349904A1 Crf receptor antagonists and methods relating thereto
05/18/2000CA2349761A1 Corticosteroid synthesis-associated genes
05/18/2000CA2349498A1 Methods and compositions for treating or preventing peripheral neuropathies
05/18/2000CA2348934A1 Phosphinate peptide analogs for the treatment of fibrotic disorders
05/18/2000CA2348727A1 Composition and method for increasing weight gain and feed efficiency
05/18/2000CA2348382A1 Chimeric parvovirus vectors and methods of making and administering the same
05/18/2000CA2347916A1 Inhibition of the formation of vascular hyperpermeability
05/17/2000EP1001034A1 Arachidonic acid and methods for the production and use thereof
05/17/2000EP1000938A1 Heterocyclic compounds as pharmaceuticals
05/17/2000EP1000158A1 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
05/17/2000EP1000085A1 Treatment of insulin resistance with growth hormone secretagogues
05/17/2000EP1000077A1 Synthetic insulin mimetic substances
05/17/2000EP1000066A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
05/17/2000EP1000057A1 Pyridyl- and pyrimidyl-heterocyclic compounds inhibiting oxido squalene-cyclase
05/17/2000EP1000056A1 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
05/17/2000EP1000055A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
05/17/2000EP1000051A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4
05/17/2000EP1000048A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
05/17/2000EP1000031A1 Vitronectin receptor antagonist
05/17/2000EP1000029A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
05/17/2000EP1000008A1 Novel thyroid receptor ligands and method
05/17/2000EP0999847A1 Health supplement
05/17/2000EP0999845A1 Treatment of diabetes with thiazolidinedione and sulphonylurea
05/17/2000EP0999843A1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use
05/17/2000EP0999842A1 Novel substituted imidazole compounds
05/17/2000EP0999841A1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
05/17/2000EP0999837A1 Treatment of diabetes with rosiglitazone and insulin
05/17/2000EP0999832A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols
05/17/2000EP0999831A1 Use of petroselinum acid for treating inflammations
05/17/2000EP0999830A1 Sertraline salts and sustained-release dosage forms of sertraline
05/17/2000EP0796238B1 Method of stabilizing polyunsaturated fatty acids and their application in therapy and cosmetics
05/17/2000EP0726768B1 Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury
05/17/2000CN1253588A Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
05/17/2000CN1253587A Methods and compositions for synthesis of long chain polyunsaturated fatty acids
05/17/2000CN1253553A Substituted phenyl derivatives, their preparation and use
05/17/2000CN1253504A Cytokine related treatments of disease
05/17/2000CN1253136A Thiazolidine derivatives and medicinal application thereof
05/17/2000CN1052419C Chinese herbal medicine for curing diabetes mellitus
05/16/2000US6063934 Neuropeptide y antagonists
05/16/2000US6063927 Paroxetine derivatives
05/16/2000US6063797 γ-RAR antagonist ligand or α-RAR agonist ligand as an apoptosis inhibitor
05/16/2000US6063796 Heterocyclic compounds of piperidine
05/16/2000US6063795 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/16/2000US6063788 Treatmrnt of artheriosclerosis
05/16/2000US6063776 Anticholesterol agents
05/16/2000US6063761 Hepatoselective pharmaceutical actives
05/16/2000US6063400 Targeted liposomal constructs for diagnostic and therapeutic uses
05/16/2000CA2027276C Novel .alpha.-glucosidase inhibitors
05/16/2000CA1340992C Process for the production of recombinant porcine growth hormone polypeptides
05/11/2000WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
05/11/2000WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
05/11/2000WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
05/11/2000WO2000026252A1 Compounds with growth hormone releasing properties
05/11/2000WO2000026245A2 Human membrane transport proteins
05/11/2000WO2000026227A1 Ldl related protein and uses thereof
05/11/2000WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/11/2000WO2000026201A1 Benzoylpyridazines
05/11/2000WO2000026192A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
05/11/2000WO2000026167A1 Vitamin d analogues
05/11/2000WO2000025803A1 Betacellulin protein-containing preparations
05/11/2000WO2000025795A1 Compositions comprising a mixture of bioflavonols
05/11/2000WO2000025794A1 Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid
05/11/2000WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
05/11/2000WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000WO2000025786A1 Heterocyclic potassium channel inhibitors
05/11/2000WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000011968A8 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID
05/11/2000DE19850701A1 Benzoylpyridazine Benzoylpyridazine
05/11/2000CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
05/11/2000CA2349232A1 Benzoylpyridazines
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2348292A1 Betacellulin protein-containing preparation
05/11/2000CA2347102A1 Compounds with growth hormone releasing properties
1 ... 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 ... 1298